Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.
British Journal of Haematology (2015)
  • Sarah A. Buckley, Fred Hutchinson Cancer Research Center
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • Pamela S. Becker, Fred Hutchinson Cancer Research Center
  • Vicky Sandhu, Fred Hutchinson Cancer Research Center
  • Paul Hendrie, Fred Hutchinson Cancer Research Center
  • Bart L. Scott, Fred Hutchinson Cancer Research Center
  • Brent L. Wood, Fred Hutchinson Cancer Research Center
  • Roland B. Walter, Fred Hutchinson Cancer Research Center
  • Kelly Smith, Fred Hutchinson Cancer Research Center
  • Carol Dean, Fred Hutchinson Cancer Research Center
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
January 8, 2015
DOI
10.1111/bjh.13437
Citation Information
Sarah A. Buckley, Raya Mawad, Ted A. Gooley, Pamela S. Becker, et al.. "A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age." British Journal of Haematology Vol. 170 Iss. 3 (2015) p. 349 - 355
Available at: http://works.bepress.com/john-pagel/75/